Xylose

Xylose

SCHEMBL21590123

CO[C@@H]([C@H](O)[C@@H](O)C=O)[C@H](O)C(=O)OC(C)=O.O=C[C@H](O)[C@@H](O)[C@H](O)CO

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27927667 0.90 ALDH1A1 (0.30)
SCHEMBL30213769 0.90 ALDH1A1 (0.30)
Xylose SCHEMBL27863624 0.82 PDE4A (0.46) PDE4A
Xylose SCHEMBL21590122 0.82 PDE4A (0.46) PDE4A
Demannose SCHEMBL27815335 0.77 LMNA (0.41) PDE4A
SCHEMBL2916061 0.77 AKR1B1 (0.34)
SCHEMBL1367677 0.77 AKR1B1 (0.34)
SCHEMBL7151920 0.77 AKR1B1 (0.34)
SCHEMBL14409028 0.77 AKR1B1 (0.34)
SCHEMBL27880442 0.77 AKR1B1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115671130-A Application of xylan in preparation of medicine or food for preventing or treating osteoporosis 广西壮族自治区中国科学院广西植物研究所 2023-02-03 CN disclosed
CN-115671129-A Application of xylan in preparing medicine or food for preventing or treating osteoporosis 广西壮族自治区中国科学院广西植物研究所 2023-02-03 CN disclosed
US-20210137965-A1 Application Of Xylan In The Preparation Of Drugs Or Food For Preventing Or Treating Osteoporosis GUANGXI INSTITUTE OF BOTANY, CHINESE ACADEMY OF SCIENCES (CN) 2021-05-13 US disclosed
WO-2019237595-A1 APPLICATIONS OF XYLAN IN PREPARING MEDICAMENT OR FOOD ITEM FOR PREVENTING OR TREATING OSTEOPOROSIS 广西壮族自治区中国科学院广西植物研究所 2019-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210137965-A1 Application Of Xylan In The Preparation Of Drugs Or Food For Preventing Or Treating Osteoporosis ALPI, COLGALT1, HEXD PDE4A 1171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.